
    
      This study will examine whether daily oral rinses with a solution containing brilacidin will
      prevent the occurrences of OM or lessen the severity of OM if it occurs. Patients will use an
      oral rinse 3 times daily for up to seven weeks during chemoradiation for head and neck
      cancer.
    
  